- 期刊
- OpenAccess
Recent Treatments of Interstitial Lung Disease with Systemic Sclerosis
並列摘要
Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.
延伸閱讀
- Lota, H. K., & Renzoni, E. A. (2012). Circulating Biomarkers of Interstitial Lung Disease in Systemic Sclerosis. International Journal of Rheumatology, 2012(), 6-15. https://doi.org/10.1155/2012/121439
- Kawasumi, H., Gono, T., & Yamanaka, Y. K. A. H. (2015). Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, (2015-S1), 9-17. https://doi.org/10.4137/CCRPM.S23313
- 許南榮、陳志毅（2008）。The Clinical Significance of Reoperation for Lung Cancer。中華民國癌症醫學會雜誌，24(6)，356-361。https://doi.org/10.6588/JCOS.2008.24.6.3
- Cheng, J. H., Chen, C. Z., Chu, Y. C., Lee, C. H., Chen, C. W., Chang, H. Y., & Hsius, T. R. (2004). Clinical Features and Prognostic Factors of Lung Abscess. 胸腔醫學, 19(6), 445-452. https://doi.org/10.29806/TM.200412.0004
- Katsumata, Y., Kawaguchi, Y., & Yamanaka, H. (2015). Interstitial Lung Disease with ANCA-associated Vasculitis. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, (2015-S1), 51-56. https://doi.org/10.4137/CCRPM.S23314